Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of α-secretase and BACE-1 concurrently

Hongjun Fu, Juan Dou, Wenming Li, Wei Cui, Shinghung Mak, Qiansheng Hu, Jialie Luo, Colin S C Lam, Yuan-Ping Pang, Moussa B H Youdim, Yifan Han

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

We have recently demonstrated that bis(7)-Cognitin, a promising multifunctional anti-Alzheimer's dimer, can remarkably reduce the generation of amyloid β peptide (Aβ) by inhibiting β-secretase (BACE-1) and activating α-secretase activity. In this study, the mechanism(s) underlying bis(7)-Cognitin's regulation of the activity of these two proteases was further investigated. In N2a cells stably expressing human amyloid precursor protein with the Swedish mutation (APPswe), the reduction in Aβ production induced by 1 μM bis(7)-Cognitin was not altered by the co-pretreatment of muscarinic and nicotinic cholinergic receptor antagonists, indicating that the regulation of APP processing by this dimer is independent of cholinergic transmission. Furthermore, bis(7)-Cognitin (0.1-3 μM) significantly increased protein kinase C (PKC) activity in cells and in vitro in a concentration-dependent manner. Administration of a PKC activator, phorbol 12-myristate 13-acetate (PMA), concentration-dependently increased the α-secretase cleavage products, and reduced the BACE-1 cleavage products. In addition, the inhibition of PKC prevented PMA- or bis(7)-Cognitin-induced alterations in α-secretase and BACE-1 activities, eliminating reductions in Aβ production seen with PMA or the dimer. These results strongly suggest that bis(7)-Cognitin may reduce the biosynthesis of Aβ by inhibiting BACE-1 and activating α-secretase concurrently through the direct activation of PKC. Combined with previous findings of direct inhibition of AChE and BACE-1 by this dimer, this work indicates that strategy may have potential to provide new insights into designing novel drugs that target multiple steps of aberrant APP processing to treat Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)14-21
Number of pages8
JournalEuropean Journal of Pharmacology
Volume623
Issue number1-3
DOIs
StatePublished - Nov 25 2009

Fingerprint

Amyloid Precursor Protein Secretases
Protein Kinase C
Acetates
Cholinergic Agents
Amyloid beta-Protein Precursor
Nicotinic Receptors
Cholinergic Antagonists
Amyloid
1,7-N-heptylene-bis-9,9'-amino-1,2,3,4-tetrahydroacridine
Alzheimer Disease
Peptide Hydrolases
Mutation
Pharmaceutical Preparations
phorbol-12-myristate

Keywords

  • α-Secretase
  • Amyloid β peptide
  • BACE-1
  • Bis(7)-Cognitin
  • Protein kinase C

ASJC Scopus subject areas

  • Pharmacology

Cite this

Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of α-secretase and BACE-1 concurrently. / Fu, Hongjun; Dou, Juan; Li, Wenming; Cui, Wei; Mak, Shinghung; Hu, Qiansheng; Luo, Jialie; Lam, Colin S C; Pang, Yuan-Ping; Youdim, Moussa B H; Han, Yifan.

In: European Journal of Pharmacology, Vol. 623, No. 1-3, 25.11.2009, p. 14-21.

Research output: Contribution to journalArticle

Fu, Hongjun ; Dou, Juan ; Li, Wenming ; Cui, Wei ; Mak, Shinghung ; Hu, Qiansheng ; Luo, Jialie ; Lam, Colin S C ; Pang, Yuan-Ping ; Youdim, Moussa B H ; Han, Yifan. / Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of α-secretase and BACE-1 concurrently. In: European Journal of Pharmacology. 2009 ; Vol. 623, No. 1-3. pp. 14-21.
@article{9bb69a75195f44a4961c625de30689d8,
title = "Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of α-secretase and BACE-1 concurrently",
abstract = "We have recently demonstrated that bis(7)-Cognitin, a promising multifunctional anti-Alzheimer's dimer, can remarkably reduce the generation of amyloid β peptide (Aβ) by inhibiting β-secretase (BACE-1) and activating α-secretase activity. In this study, the mechanism(s) underlying bis(7)-Cognitin's regulation of the activity of these two proteases was further investigated. In N2a cells stably expressing human amyloid precursor protein with the Swedish mutation (APPswe), the reduction in Aβ production induced by 1 μM bis(7)-Cognitin was not altered by the co-pretreatment of muscarinic and nicotinic cholinergic receptor antagonists, indicating that the regulation of APP processing by this dimer is independent of cholinergic transmission. Furthermore, bis(7)-Cognitin (0.1-3 μM) significantly increased protein kinase C (PKC) activity in cells and in vitro in a concentration-dependent manner. Administration of a PKC activator, phorbol 12-myristate 13-acetate (PMA), concentration-dependently increased the α-secretase cleavage products, and reduced the BACE-1 cleavage products. In addition, the inhibition of PKC prevented PMA- or bis(7)-Cognitin-induced alterations in α-secretase and BACE-1 activities, eliminating reductions in Aβ production seen with PMA or the dimer. These results strongly suggest that bis(7)-Cognitin may reduce the biosynthesis of Aβ by inhibiting BACE-1 and activating α-secretase concurrently through the direct activation of PKC. Combined with previous findings of direct inhibition of AChE and BACE-1 by this dimer, this work indicates that strategy may have potential to provide new insights into designing novel drugs that target multiple steps of aberrant APP processing to treat Alzheimer's disease.",
keywords = "α-Secretase, Amyloid β peptide, BACE-1, Bis(7)-Cognitin, Protein kinase C",
author = "Hongjun Fu and Juan Dou and Wenming Li and Wei Cui and Shinghung Mak and Qiansheng Hu and Jialie Luo and Lam, {Colin S C} and Yuan-Ping Pang and Youdim, {Moussa B H} and Yifan Han",
year = "2009",
month = "11",
day = "25",
doi = "10.1016/j.ejphar.2009.09.013",
language = "English (US)",
volume = "623",
pages = "14--21",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of α-secretase and BACE-1 concurrently

AU - Fu, Hongjun

AU - Dou, Juan

AU - Li, Wenming

AU - Cui, Wei

AU - Mak, Shinghung

AU - Hu, Qiansheng

AU - Luo, Jialie

AU - Lam, Colin S C

AU - Pang, Yuan-Ping

AU - Youdim, Moussa B H

AU - Han, Yifan

PY - 2009/11/25

Y1 - 2009/11/25

N2 - We have recently demonstrated that bis(7)-Cognitin, a promising multifunctional anti-Alzheimer's dimer, can remarkably reduce the generation of amyloid β peptide (Aβ) by inhibiting β-secretase (BACE-1) and activating α-secretase activity. In this study, the mechanism(s) underlying bis(7)-Cognitin's regulation of the activity of these two proteases was further investigated. In N2a cells stably expressing human amyloid precursor protein with the Swedish mutation (APPswe), the reduction in Aβ production induced by 1 μM bis(7)-Cognitin was not altered by the co-pretreatment of muscarinic and nicotinic cholinergic receptor antagonists, indicating that the regulation of APP processing by this dimer is independent of cholinergic transmission. Furthermore, bis(7)-Cognitin (0.1-3 μM) significantly increased protein kinase C (PKC) activity in cells and in vitro in a concentration-dependent manner. Administration of a PKC activator, phorbol 12-myristate 13-acetate (PMA), concentration-dependently increased the α-secretase cleavage products, and reduced the BACE-1 cleavage products. In addition, the inhibition of PKC prevented PMA- or bis(7)-Cognitin-induced alterations in α-secretase and BACE-1 activities, eliminating reductions in Aβ production seen with PMA or the dimer. These results strongly suggest that bis(7)-Cognitin may reduce the biosynthesis of Aβ by inhibiting BACE-1 and activating α-secretase concurrently through the direct activation of PKC. Combined with previous findings of direct inhibition of AChE and BACE-1 by this dimer, this work indicates that strategy may have potential to provide new insights into designing novel drugs that target multiple steps of aberrant APP processing to treat Alzheimer's disease.

AB - We have recently demonstrated that bis(7)-Cognitin, a promising multifunctional anti-Alzheimer's dimer, can remarkably reduce the generation of amyloid β peptide (Aβ) by inhibiting β-secretase (BACE-1) and activating α-secretase activity. In this study, the mechanism(s) underlying bis(7)-Cognitin's regulation of the activity of these two proteases was further investigated. In N2a cells stably expressing human amyloid precursor protein with the Swedish mutation (APPswe), the reduction in Aβ production induced by 1 μM bis(7)-Cognitin was not altered by the co-pretreatment of muscarinic and nicotinic cholinergic receptor antagonists, indicating that the regulation of APP processing by this dimer is independent of cholinergic transmission. Furthermore, bis(7)-Cognitin (0.1-3 μM) significantly increased protein kinase C (PKC) activity in cells and in vitro in a concentration-dependent manner. Administration of a PKC activator, phorbol 12-myristate 13-acetate (PMA), concentration-dependently increased the α-secretase cleavage products, and reduced the BACE-1 cleavage products. In addition, the inhibition of PKC prevented PMA- or bis(7)-Cognitin-induced alterations in α-secretase and BACE-1 activities, eliminating reductions in Aβ production seen with PMA or the dimer. These results strongly suggest that bis(7)-Cognitin may reduce the biosynthesis of Aβ by inhibiting BACE-1 and activating α-secretase concurrently through the direct activation of PKC. Combined with previous findings of direct inhibition of AChE and BACE-1 by this dimer, this work indicates that strategy may have potential to provide new insights into designing novel drugs that target multiple steps of aberrant APP processing to treat Alzheimer's disease.

KW - α-Secretase

KW - Amyloid β peptide

KW - BACE-1

KW - Bis(7)-Cognitin

KW - Protein kinase C

UR - http://www.scopus.com/inward/record.url?scp=70350210477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350210477&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2009.09.013

DO - 10.1016/j.ejphar.2009.09.013

M3 - Article

C2 - 19765582

AN - SCOPUS:70350210477

VL - 623

SP - 14

EP - 21

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -